Product Information
CAPTOPRIL 12.5 MG TABLET is a generic product labeled by Ajanta Pharma USA Inc., priced at $0.2477 per EA under NDC 27241016001. Its NADAC has been published 298 times since Oct 14, 2020.
Strength
12.5 mg/1
Manufacturer
Ajanta Pharma USA Inc.NDC
27241016001
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CAPTOPRILApproval Type
Generic (ANDA)
FDA Application
ANDA212809On Market Since
12/13/2019
Pharmacological Classes
Price Statistics
The NADAC for CAPTOPRIL 12.5 MG TABLET has been published 298 times since Oct 14, 2020, and over the history we have for it it has declined 67.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2477 per EA |
|---|---|
| All-time high | $0.7541 (Dec 16, 2020) |
| All-time low | $0.1816 (Mar 19, 2025) |
| 52-week high | $0.4059 |
| 52-week low | $0.2477 |
| Median price | $0.4353 |
| Average price | $0.4416 |
| Largest weekly change | +125.8% (Aug 17, 2022) |
| Weeks tracked | 298 |
| Tracking since | Oct 14, 2020 |
Generic Alternatives
The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CAPTOPRIL 12.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CAPTOPRIL 12.5 MG TABLET, manufactured by Ajanta Pharma USA Inc., is $0.2477 per EA (NDC 27241016001), effective Jun 24, 2026.
How has the price of CAPTOPRIL 12.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for CAPTOPRIL 12.5 MG TABLET has declined 67.2%. It has been tracked across 298 weekly CMS publications since Oct 14, 2020.
What are the highest and lowest recorded NADAC prices for CAPTOPRIL 12.5 MG TABLET?
Since Oct 14, 2020, the NADAC for CAPTOPRIL 12.5 MG TABLET has ranged from a low of $0.1816 (Mar 19, 2025) to a high of $0.7541 (Dec 16, 2020), with a median of $0.4353 per EA.
Are there cheaper alternatives to CAPTOPRIL 12.5 MG TABLET?
6 NADAC-published products share the same active ingredient, strength, and dosage form as CAPTOPRIL 12.5 MG TABLET, but none are currently priced below it.
Who manufactures CAPTOPRIL 12.5 MG TABLET?
CAPTOPRIL 12.5 MG TABLET (NDC 27241016001) is labeled by Ajanta Pharma USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification